Companies › ARVN
ARVINAS INC (ARVN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001655759 · EDGAR filings · Updated 2026-07-09
ARVINAS INC (ARVN) has reported institutional ownership of 83.9%, with 206 institutional managers holding positions valued at $571.9M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-09 — Notice of proposed sale filed (Form 144)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ARVINAS INC has 206 institutional holders and institutional ownership of 83.9%.
Insider activity
Insiders reported 37 transactions (2 buys, 17 sells) across 14 reporting insiders, with a net reported value of −$470.7K.
Data flags from SEC filings
Related companies
BIOAGE LABS INC (BIOA) · MEIRAGTX HLDGS PLC (MGTX) · RELMADA THERAPEUTICS INC (RLMD) · IRONWOOD PHARMACEUTICALS INC (IRWD) · BUTTERFLY NETWORK INC (BFLY) · TACTILE SYS TECHNOLOGY INC (TCMD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.